États-Unis · Bourse & Finance · The Wall Street Journal

Germany’s Merck to Buy U.K. Biotech Silence Therapeutics for $1.3 Billion

Publié par The Wall Street Journal · États-Unis il y a 9 h

Merck said it is offering $20 in cash for each American depositary share for Nasdaq-listed Silence Therapeutics, more than double the target’s closing price as of Friday.

Lire l'article complet sur The Wall Street Journal Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.wsj.com)

Germany’s Merck to Buy U.K. Biotech Silence Therapeutics for $1.3 Billion

À lire aussi

Women may be at greater risk of AI job losses. Telephone switch operators and PCs show why

AI could eat Big Law's billable hours. Cooley's boss says bring it on.

Trump Defends Russia Sanctions Waiver as Rift With Ukraine Deepens

Made an ‘honest’ mistake with crypto taxes? New bill offers way out

How Boston Dynamics is turning robots into a real business

Strategy Buys $22M in Bitcoin, Buys Back $193M of STRC

Germany’s Merck to Buy U.K. Biotech Silence Therapeutics for $1.3 Billion

Partager

À lire aussi

Women may be at greater risk of AI job losses. Telephone switch operators and PCs show why

AI could eat Big Law's billable hours. Cooley's boss says bring it on.

Trump Defends Russia Sanctions Waiver as Rift With Ukraine Deepens

Made an ‘honest’ mistake with crypto taxes? New bill offers way out

How Boston Dynamics is turning robots into a real business

Strategy Buys $22M in Bitcoin, Buys Back $193M of STRC